11/19
04:09 pm
drts
Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/19
04:00 pm
drts
Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
11/13
08:30 am
drts
Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference
Medium
Report
Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference
11/1
01:43 pm
drts
Discover Alpha Tau Medical And 2 Other US Penny Stocks [Yahoo! Finance]
Low
Report
Discover Alpha Tau Medical And 2 Other US Penny Stocks [Yahoo! Finance]
10/23
08:18 am
drts
Alpha Tau Medical Ltd. (NASDAQ: DRTS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
Alpha Tau Medical Ltd. (NASDAQ: DRTS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
10/21
08:30 am
drts
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
Medium
Report
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
10/11
08:41 am
drts
Alpha Tau Medical Ltd. (NASDAQ: DRTS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
Alpha Tau Medical Ltd. (NASDAQ: DRTS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
10/10
08:30 am
drts
Alpha Tau Treats First Patient with Recurrent Lung Cancer
Low
Report
Alpha Tau Treats First Patient with Recurrent Lung Cancer
9/23
07:59 am
drts
FDA approves study of Alpha Tau's Alpha DaRT for recurrent cSCC treatment [Yahoo! Finance]
Medium
Report
FDA approves study of Alpha Tau's Alpha DaRT for recurrent cSCC treatment [Yahoo! Finance]
9/20
08:30 am
drts
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
Medium
Report
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC